London, 18 September 2019, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is proud to have supported CMR Surgical, the company developing, manufacturing and marketing the next-generation surgical robotic system, Versius®, on the international communication of its £195 million ($240 million) fundraise.
The fundraise has been supported by existing investors: LGT, Escala Capital Investments, Cambridge Innovation Capital, Watrium, and Zhejiang Silk Road Fund as well as new US investors with deep sector knowledge. This financing is Europe’s largest private financing round in the medical technology sector and will fund the business through the planned global commercialisation of Versius® whilst supporting continued research and development, manufacturing and expansion.
“Consilium has provided strategic advice and international media management to CMR Surgical for approximately five years during which time we have enjoyed seeing the company rapidly grow and develop its game-changing surgical robot. This latest fundraise is testament to the huge potential and investment appeal of the Versius system. We would like to congratulate the team at CMR on this successful fundraise and we look forward to continuing to work with the company as they prepare for the imminent commercial launch of the Versius system.”
Mary-Jane Elliott
Managing Partner of Consilium Strategic Communications
The Consilium team representing CMR Surgical on the financing was: Mary-Jane Elliott, Angela Gray, Lindsey Neville and Lizzie Seeley in Europe and Catherine London in US.
To view CMR Surgical’s announcement please visit https://cmrsurgical.com/.
